Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro (English)
- New search for: Rigalli, Juan Pablo
- New search for: Reuter, Tasmin
- New search for: Herold-Mende, Christel
- New search for: Dyckhoff, Gerhard
- New search for: Haefeli, Walter Emil
- New search for: Weiss, Johanna
- New search for: Theile, Dirk
- New search for: Rigalli, Juan Pablo
- New search for: Reuter, Tasmin
- New search for: Herold-Mende, Christel
- New search for: Dyckhoff, Gerhard
- New search for: Haefeli, Walter Emil
- New search for: Weiss, Johanna
- New search for: Theile, Dirk
In:
Cancer Chemotherapy and Pharmacology
;
71
, 5
; 1335-1343
;
2013
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro
-
Contributors:Rigalli, Juan Pablo ( author ) / Reuter, Tasmin ( author ) / Herold-Mende, Christel ( author ) / Dyckhoff, Gerhard ( author ) / Haefeli, Walter Emil ( author ) / Weiss, Johanna ( author ) / Theile, Dirk ( author )
-
Published in:Cancer Chemotherapy and Pharmacology ; 71, 5 ; 1335-1343
-
Publisher:
- New search for: Springer-Verlag
- New search for: Springer
-
Place of publication:Berlin
-
Publication date:2013
-
ISSN:
-
ZDBID:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
- New search for: 44.40 / 44.38
- Further information on Basic classification
-
Keywords:
-
Classification:
-
Source:
Table of contents – Volume 71, Issue 5
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1107
-
Principles of dose finding studies in cancer: a comparison of trial designsJaki, Thomas / Clive, Sally / Weir, Christopher J. et al. | 2013
- 1115
-
A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritisAbolmaali, Samira Sadat / Tamaddon, Ali Mohammad / Dinarvand, Rassoul et al. | 2013
- 1131
-
Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel-loaded microsphere with larotaxel-solutionLiu, Zhenzhen / Feng, Yukun / Zhang, Lunhui / Li, Guofei / Geng, Lulu / Cui, Yan / Teng, Fei / Tang, Xing / Bi, Kaishun / Chen, Xiaohui et al. | 2013
- 1141
-
A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancerSuzuki, Eiichiro / Ikeda, Masafumi / Okusaka, Takuji / Nakamori, Shoji / Ohkawa, Shinichi / Nagakawa, Tatsuya / Boku, Narikazu / Yanagimoto, Hiroaki / Sato, Tosiya / Furuse, Junji et al. | 2013
- 1147
-
Predictive pharmacokinetic–pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenograftsRocchetti, Maurizio / Germani, Massimiliano / Del Bene, Francesca / Poggesi, Italo / Magni, Paolo / Pesenti, Enrico / De Nicolao, Giuseppe et al. | 2013
- 1159
-
Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxelWu, Hao / Huang, Min / Lu, Mingjie / Zhu, Wei / Shu, Yongqian / Cao, Peng / Liu, Ping et al. | 2013
- 1173
-
A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancerRamnath, N. / Daignault-Newton, S. / Dy, G. K. / Muindi, J. R. / Adjei, A. / Elingrod, V. L. / Kalemkerian, G. P. / Cease, K. B. / Stella, P. J. / Brenner, D. E. et al. | 2013
- 1183
-
Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancerLayman, Rachel M. / Ruppert, Amy S. / Lynn, Melinda / Mrozek, Ewa / Ramaswamy, Bhuvaneswari / Lustberg, Maryam B. / Wesolowski, Robert / Ottman, Susan / Carothers, Sarah / Bingman, Anissa et al. | 2013
- 1191
-
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiationPlummer, Ruth / Lorigan, Paul / Steven, Neil / Scott, Lucy / Middleton, Mark R. / Wilson, Richard H. / Mulligan, Evan / Curtin, Nicola / Wang, Diane / Dewji, Raz et al. | 2013
- 1201
-
Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapyLee, Soo Jung / Kim, Jong Gwang / Lee, Sang-Woo / Chae, Yee Soo / Kang, Byung Woog / Lee, Yoo Jin / Park, Jun Seok / Choi, Gyu Seog et al. | 2013
- 1209
-
A preclinical study on the protective effect of melatonin against methotrexate-induced small intestinal damage: effect mediated by attenuation of nitrosative stress, protein tyrosine nitration, and PARP activationKolli, Viswa Kalyan / Kanakasabapathy, Indirani / Faith, Minnie / Ramamoorthy, Hemalatha / Isaac, Bina / Natarajan, Kasthuri / Abraham, Premila et al. | 2013
- 1219
-
Physiologically based pharmacokinetic models for everolimus and sorafenib in micePawaskar, Dipti K. / Straubinger, Robert M. / Fetterly, Gerald J. / Hylander, Bonnie H. / Repasky, Elizabeth A. / Ma, Wen W. / Jusko, William J. et al. | 2013
- 1231
-
Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in micePawaskar, Dipti K. / Straubinger, Robert M. / Fetterly, Gerald J. / Hylander, Bonnie H. / Repasky, Elizabeth A. / Ma, Wen W. / Jusko, William J. et al. | 2013
- 1241
-
Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumorsChan, Jennifer A. / Mayer, Robert J. / Jackson, Nadine / Malinowski, Paige / Regan, Eileen / Kulke, Matthew H. et al. | 2013
- 1247
-
A phase I pharmacokinetic study of PM00104 ($ Zalypsis^{®} $) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumorsCapdevila, J. / Clive, S. / Casado, E. / Michie, C. / Piera, A. / Sicart, E. / Carreras, M. J. / Coronado, C. / Kahatt, C. / Soto Matos-Pita, A. et al. | 2013
- 1255
-
Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1Zhai, Jing-Ming / Yin, Xiao-Yu / Lai, Ying-Rong / Hou, Xun / Cai, Jian-Peng / Hao, Xiao-Yi / Liang, Li-Jian / Zhang, Long-Juan et al. | 2013
- 1265
-
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosisFushida, S. / Kinoshita, J. / Kaji, M. / Hirono, Y. / Goda, F. / Yagi, Y. / Oyama, K. / Sudo, Y. / Watanabe, Y. / Fujimura, T. et al. | 2013
- 1273
-
A phase I trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignanciesChow, Laura Q. M. / Jonker, Derek I. / Dy, Grace K. / Nicholas, Garth / Fortin, Catherine / Patricia, Daniel / Adjei, Alex A. / Belani, Chandra P. / Gupta, Ashok / Park, Jong-Soon et al. | 2013
- 1287
-
Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancerZhao, Wan / Hu, Lingmin / Xu, Jiali / Shen, Hongbing / Hu, Zhibin / Ma, Hongxia / Shu, Yongqian / Shao, Yongfeng / Yin, Yongmei et al. | 2013
- 1297
-
Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenibSerova, Maria / de Gramont, Armand / Tijeras-Raballand, Annemilaï / Dos Santos, Célia / Riveiro, Maria Eugenia / Slimane, Khemaies / Faivre, Sandrine / Raymond, Eric et al. | 2013
- 1309
-
Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancerTsuburaya, Akira / Nagata, Naoki / Cho, Haruhiko / Hirabayashi, Naoki / Kobayashi, Michiya / Kojima, Hiroshi / Munakata, Yasuhiro / Fukushima, Ryoji / Kameda, Yoichi / Shimoda, Tadakazu et al. | 2013
- 1315
-
Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer modelsGozgit, Joseph M. / Squillace, Rachel M. / Wongchenko, Matthew J. / Miller, David / Wardwell, Scott / Mohemmad, Qurish / Narasimhan, Narayana I. / Wang, Frank / Clackson, Tim / Rivera, Victor M. et al. | 2013
- 1325
-
Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancerSudo, Makoto / Chin, Tan Min / Mori, Seiichi / Doan, Ngan B. / Said, Jonathan W. / Akashi, Makoto / Koeffler, H. Phillip et al. | 2013
- 1335
-
Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitroRigalli, Juan Pablo / Reuter, Tasmin / Herold-Mende, Christel / Dyckhoff, Gerhard / Haefeli, Walter Emil / Weiss, Johanna / Theile, Dirk et al. | 2013
- 1345
-
Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumorsSaif, M. W. / Erlichman, C. / Dragovich, T. / Mendelson, D. / Toft, D. / Burrows, F. / Storgard, C. / Von Hoff, D. et al. | 2013
- 1357
-
The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasiasO’Connor, Robert / Ooi, Melissa G. / Meiller, Justine / Jakubikova, Jana / Klippel, Steffen / Delmore, Jake / Richardson, Paul / Anderson, Kenneth / Clynes, Martin / Mitsiades, Constantine S. et al. | 2013
- 1369
-
A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancerYunokawa, Mayu / Katsumata, Noriyuki / Yamamoto, Harukaze / Kodaira, Makoto / Yonemori, Kan / Shimizu, Chikako / Ando, Masashi / Tamura, Kenji / Fujiwara, Yasuhiro et al. | 2013
- 1375
-
Phase II randomized trial of carboplatin and gemcitabine with or without dexamethasone pre-treatment in patients with Stage IV non-small cell lung cancerRinehart, John / Arnold, Susanne / Kloecker, Goetz / Lim, Allen / Zaydan, Muhammad-Ali / Baeker, Thomas / Maheshwari, Jewraj G. / Carloss, Harry / Slone, Stacey / Shelton, Brent et al. | 2013
- 1385
-
Dodging a dogma: is treating beyond progression beneficial?Naing, Aung / Kurzrock, Razelle et al. | 2013